{
  "Question": "SquareMind CES 2024 product highlight and specification",
  "Summary": "SquareMind\n\nProduct: Swan\n\n- A disruptive software technology for skin cancer detection\n- Aims to make skin screening more accessible through digitization and leveraging AI\n- Intends to free up significant medical time and provide physicians with more data\n- Supported by Calm/Storm Ventures, Entrepreneur First, id4 ventures, EIC Accelerator innovation programme, Bpifrance, and business angels\n- Envisions a future of non-invasive healthcare and autonomous robots revolutionizing healthcare systems\n- Not commercially available yet, but set to be revealed in 2024\n- Global vision with current activities in Europe and the US"
}